Frontlight ResearchEarly access
Enrolling by invitationNo phase
Patient-Centered Practical Vaccine Talk For Busy Clinicians
Key facts
- Who runs it
- University of Massachusetts, Worcester
- Where
- Worcester, United StatesSee the site
- Trial code
- Status
- Enrolling by invitation
- People taking part
- 24,500 people, planned
- Started
- 24 Jun 2026
- Expected to end
- 15 May 2028
- Type of study
- Interventional, 2 groupsOne group gets no study treatment, for comparison.
- Treatments tested
- Provider communication training
- Record updated
- 29 June 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 13 criteriaShow less
Who can take part
- Practicing primary care provider at study clinic during the study period
- Licensed independent practitioner (MD, DO, NP, PA), including residents
- Receipt of the 2026/2027 influenza vaccine, among eligible patients:
- Have a qualifying clinic visit, defined as a clinic visit with a study PCP at one of the study clinics during the 2026/2027 influenza vaccine season*
- Have not received the 2026-2027 influenza vaccine prior to the qualifying clinic visit (patients who receive the influenza vaccine on the day of the qualifying study visit are eligible)
- Adult (age >= 18 years); Receipt of the 2026/2027 COVID-19 vaccine, among eligible patients:
- Have a qualifying clinic visit, defined as a clinic visit with a study PCP at one of the study clinics during the 2026/2027 COVID-19 vaccine season*
- Have not received the 2026-2027 COVID-19 vaccine prior to the qualifying study visit (patients who receive the COVID-19 vaccine on the day of the qualifying study visit are eligible)
- Have at least one risk factor for developing severe COVID-19 according to the CDC, including age >= 65 years
- Adult (age >= 19 years)
Who cannot take part
- Resident of a state that does not share immunization data with the Massachusetts Immunization Information System (MIIS); For the purposes of this study, the 2026/2027 influenza and COVID-19 vaccine seasons are defined as September 1, 2026, or date the respective vaccine is available (whichever is later) through February 28, 2027. These dates were selected based on the timing of influenza and COVID-19 vaccine administration in prior years according to the Massachusetts immunization for respiratory disease data. This is referred to as the 'study period' elsewhere in the protocol
- PCPs at participating clinic sites who are members of the investigational team or part of the intervention
- PCP participants who practice at more than one study clinic that are assigned to discordant study arms (e.g., control and intervention) will be excluded at the outset of the study
Where in United States
- UMass Chan Medical SchoolWorcester, United StatesEnrolling by invitation
About the trial
What the trial wants to find out
The goal of this study is to assess the effect of an educational intervention for primary care providers (PCPs) on influenza and COVID-19 vaccine uptake among their adult patients through a pragmatic, cluster randomized trial in primary care clinics.
The 2 groups in the trial
- Intervention ArmOther group
Provider educational intervention.
Treatment: Provider communication training
- Control ArmNo study treatment, for comparison
Usual care
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Patient-Centered Practical Vaccine Talk for Busy Clinicians (PCP-VAX): An Educational Intervention for Primary Care Providers on Influenza and COVID-19 Vaccine Uptake Among Adult Primary Care Patients
- Record updated
- 29 June 2026